SCHEMBL4545470

SCHEMBL4545470

CCOC(=O)c1occ(Br)c(=O)c1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.41
ALOX15 P16050 2/20 0.41
TSHR P16473 2/20 0.41
GAA P10253 2/20 0.41
PKM P14618 2/20 0.41
HSD17B10 Q99714 1/20 0.41
MAOB P27338 2/20 0.40
PTPN11 Q06124 2/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
CA12 O43570 3/20 0.38
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA7 P43166 3/20 0.38
CA9 Q16790 3/20 0.38
CA14 Q9ULX7 3/20 0.38
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4545465 0.82 GAA (0.35) MAPTTSHRGAAPTPN11CA12
SCHEMBL3979225 0.80 MAPT (0.41) MAPTALOX15TSHRGAAPKM
SCHEMBL4549798 0.77 THRA (0.41) MAPTALOX15TSHRGAAHSD17B10
SCHEMBL8066761 0.72 L3MBTL1 (0.44) MAPTTSHRHSD17B10MAOBNPC1
SCHEMBL3977290 0.72 MAPT (0.50) MAPTTSHRGAAMAOBNPC1
SCHEMBL106736 0.70 TSHR (0.44) MAPTALOX15TSHRPKMHSD17B10
SCHEMBL18233765 0.70 MAOB (0.41) MAPTTSHRMAOBNPC1RAB9A
SCHEMBL21649081 0.69 KDM4E (0.38) MAPTTSHRGAACA12CA1
SCHEMBL11273191 0.69 MAPT (0.47) MAPTALOX15TSHRGAAHSD17B10
SCHEMBL15143780 0.69 MAOB (0.54) MAPTTSHRGAAHSD17B10MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2540720-A1 1,3,4,8-TETRAHYDRO-2H-PYRIDO[1,2-A]PYRAZINE DERIVATIVE AND USE OF SAME AS HIV INTEGRASE INHIBITOR Japan Tobacco, Inc. (JP) 2013-01-02 EP disclosed
US-20120108564-A1 1,3,4,8-Tetrahydro-2H-Pyrido[1,2-a]Pyradine Derivatives and Use Thereof as HIV Integrase Inhibitor JAPAN TOBACCO INC. (JP) 2012-05-03 US disclosed
US-20120108564-A1 1,3,4,8-Tetrahydro-2H-Pyrido[1,2-a]Pyradine Derivatives and Use Thereof as HIV Integrase Inhibitor JAPAN TOBACCO INC. (JP) 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108564-A1 1,3,4,8-Tetrahydro-2H-Pyrido[1,2-a]Pyradine Derivatives and Use Thereof as HIV Integrase Inhibitor IMPDH1, IMPA1, DPYD MAPT 1853/4885ALOX15 3362/4885TSHR 4656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.